Cargando…

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection

The immune response to SARS-CoV-2 is critical in controlling disease but there is concern that waning immunity may predispose to re-infection. We analysed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at six months following infection. T-cell responses were pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Jianmin, Dowell, Alexander C., Pearce, Hayden, Verma, Kriti, Long, Heather M., Begum, Jusnara, Aiano, Felicity, Amin-Chowdhury, Zahin, Hallis, Bassam, Stapley, Lorrain, Borrow, Ray, Linley, Ezra, Ahmad, Shazaad, Parker, Ben, Horsley, Alex, Amirthalingam, Gayatri, Brown, Kevin, Ramsay, Mary E., Ladhani, Shamez, Moss, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610739/
https://www.ncbi.nlm.nih.gov/pubmed/33674800
http://dx.doi.org/10.1038/s41590-021-00902-8
_version_ 1783605226688741376
author Zuo, Jianmin
Dowell, Alexander C.
Pearce, Hayden
Verma, Kriti
Long, Heather M.
Begum, Jusnara
Aiano, Felicity
Amin-Chowdhury, Zahin
Hallis, Bassam
Stapley, Lorrain
Borrow, Ray
Linley, Ezra
Ahmad, Shazaad
Parker, Ben
Horsley, Alex
Amirthalingam, Gayatri
Brown, Kevin
Ramsay, Mary E.
Ladhani, Shamez
Moss, Paul
author_facet Zuo, Jianmin
Dowell, Alexander C.
Pearce, Hayden
Verma, Kriti
Long, Heather M.
Begum, Jusnara
Aiano, Felicity
Amin-Chowdhury, Zahin
Hallis, Bassam
Stapley, Lorrain
Borrow, Ray
Linley, Ezra
Ahmad, Shazaad
Parker, Ben
Horsley, Alex
Amirthalingam, Gayatri
Brown, Kevin
Ramsay, Mary E.
Ladhani, Shamez
Moss, Paul
author_sort Zuo, Jianmin
collection PubMed
description The immune response to SARS-CoV-2 is critical in controlling disease but there is concern that waning immunity may predispose to re-infection. We analysed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at six months following infection. T-cell responses were present by ELISPOT and/or ICS analysis in all donors and characterised by predominant CD4+ T cell responses with strong IL-2 cytokine expression. Median T-cell responses were 50% higher in donors who had experienced a symptomatic infection indicating that the severity of primary infection establishes a ‘setpoint’ for cellular immunity. T-cell responses to spike and nucleoprotein/membrane proteins were correlated with peak antibody levels. Furthermore, higher levels of nucleoprotein-specific T cells were associated with preservation of NP-specific antibody level although no such correlation was observed in relation to spike-specific responses. In conclusion, our data are reassuring that functional SARS-CoV-2-specific T-cell responses are retained at six months following infection.
format Online
Article
Text
id pubmed-7610739
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-76107392021-09-05 Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection Zuo, Jianmin Dowell, Alexander C. Pearce, Hayden Verma, Kriti Long, Heather M. Begum, Jusnara Aiano, Felicity Amin-Chowdhury, Zahin Hallis, Bassam Stapley, Lorrain Borrow, Ray Linley, Ezra Ahmad, Shazaad Parker, Ben Horsley, Alex Amirthalingam, Gayatri Brown, Kevin Ramsay, Mary E. Ladhani, Shamez Moss, Paul Nat Immunol Article The immune response to SARS-CoV-2 is critical in controlling disease but there is concern that waning immunity may predispose to re-infection. We analysed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at six months following infection. T-cell responses were present by ELISPOT and/or ICS analysis in all donors and characterised by predominant CD4+ T cell responses with strong IL-2 cytokine expression. Median T-cell responses were 50% higher in donors who had experienced a symptomatic infection indicating that the severity of primary infection establishes a ‘setpoint’ for cellular immunity. T-cell responses to spike and nucleoprotein/membrane proteins were correlated with peak antibody levels. Furthermore, higher levels of nucleoprotein-specific T cells were associated with preservation of NP-specific antibody level although no such correlation was observed in relation to spike-specific responses. In conclusion, our data are reassuring that functional SARS-CoV-2-specific T-cell responses are retained at six months following infection. 2021-05-01 2021-03-05 /pmc/articles/PMC7610739/ /pubmed/33674800 http://dx.doi.org/10.1038/s41590-021-00902-8 Text en http://www.nature.com/authors/editorial_policies/license.html#termsUsers may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Zuo, Jianmin
Dowell, Alexander C.
Pearce, Hayden
Verma, Kriti
Long, Heather M.
Begum, Jusnara
Aiano, Felicity
Amin-Chowdhury, Zahin
Hallis, Bassam
Stapley, Lorrain
Borrow, Ray
Linley, Ezra
Ahmad, Shazaad
Parker, Ben
Horsley, Alex
Amirthalingam, Gayatri
Brown, Kevin
Ramsay, Mary E.
Ladhani, Shamez
Moss, Paul
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
title Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
title_full Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
title_fullStr Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
title_full_unstemmed Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
title_short Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
title_sort robust sars-cov-2-specific t-cell immunity is maintained at 6 months following primary infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610739/
https://www.ncbi.nlm.nih.gov/pubmed/33674800
http://dx.doi.org/10.1038/s41590-021-00902-8
work_keys_str_mv AT zuojianmin robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT dowellalexanderc robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT pearcehayden robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT vermakriti robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT longheatherm robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT begumjusnara robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT aianofelicity robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT aminchowdhuryzahin robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT hallisbassam robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT stapleylorrain robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT borrowray robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT linleyezra robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT ahmadshazaad robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT parkerben robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT horsleyalex robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT amirthalingamgayatri robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT brownkevin robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT ramsaymarye robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT ladhanishamez robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection
AT mosspaul robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection